H.R. 2009 (105th): Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997

Jun 23, 1997 (105th Congress, 1997–1998)
Died (Referred to Committee)
Walter Capps
Representative for California's 22nd congressional district
Read Text »
Last Updated
Jun 23, 1997
6 pages

This bill was introduced on June 23, 1997, in a previous session of Congress, but was not enacted.

Introduced Jun 23, 1997
Referred to Committee Jun 23, 1997
Full Title

To amend the Social Security Act to waive the 24 month waiting period for Medicare coverage of individuals disabled with amyotrophic lateral sclerosis (ALS), to provide Medicare coverage of drugs used for treatment of ALS, and to amend the Public Health Service Act to increase Federal funding for research on ALS.


No summaries available.

144 cosponsors (102D, 39R, 1I, 1D, 1D) (show)

House Energy and Commerce

House Ways and Means


The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997 - Amends title II (Old Age, Survivors and Disability Insurance) of the Social Security Act (SSA) to provide for a waiver of the 24-month waiting period for Medicare coverage for individuals disabled by amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease. Amends SSA title XVIII (Medicare) to provide for Medicare coverage of any drug approved by the Food and Drug Administration for use in the treatment or alleviation of ALS-related symptoms.
Authorizes appropriations, in addition to any already available, for ALS research through the National Institutes of Health.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 2009 (105th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus